A phase I, open-label, multiple single doses and one repeated dose study of CAM2043 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 31 May 2018
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- 31 May 2018 Topline results presented in the Camurus media release.
- 15 Feb 2018 According to a Camurus media release, initial results from this study are expected during Q2 2018.
- 21 Dec 2017 According to a Camurus media release, first cohort has been dosed in the trial.